No Data
UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)
Novartis AG Receives Health Canada Approval For Vanrafia To Reduce Preoteinuria Production In Immunoglobulin A Nephropathy Patients
Novartis AG Rises Monday
Converging at BIO, ACROBiosystems Connects Emerging Innovation Assets With Global Strategic Opportunities
Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight
Can AI Make Better Drugs? Not on Wall Street's Timeline -- Heard on the Street -- WSJ